GPR30 knockdown decreased p-Akt and PD-L1 levels (Fig. 8C and D), and Akt knockdown also inhibited PD-L1 protein expression in HCT116 and HT29 colon cancer cells (Fig. 8E and F). Here, AKT1 is linked to colonic neoplasm.